Skin glue may give better C-Section scars than stitches
NCT ID NCT06760026
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether using a medical skin glue (2-octylcyanoacrylate) instead of traditional stitches leads to better-looking scars after a C-section. 36 women who had planned C-sections took part. The goal was to see if the glue improves scar color, thickness, and flexibility, and reduces complications.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- 2-octylcyanoacrylate tissue adhesive
- What this could lead to
- If this works, it could offer a simpler, less invasive way to close C-section wounds with better-looking scars.
- What could go wrong
- This is a small, completed trial with only 36 participants, so results may not apply to everyone. The cosmetic benefit may be minimal or no better than standard sutures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
36 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Submission of a signed and dated informed consent form. * Declared willingness to comply with all study procedures and availability for the duration of the study. * Pregnant patient at 37 or more weeks gestation, scheduled for elective cesarean section at the Hospital Materno Infantil. * Cesarean section performed in the Maternity and Children's Hospital, operating room. * Literate patient, able to understand and respond to the study questions, with body mass index less than 30. * Possess cell phone or other means of communication to facilitate postoperative follow-up. * Residing in the city of Tegucigalpa, Honduras, to ensure accessibility to scheduled follow-up visits. Exclusion Criteria: * Patients under 18 years of age. * Patients with diagnosed psychiatric illnesses that may interfere with their ability to give informed consent or follow the study protocol. * Pregnant patients with complications that may affect the healing process or increase the risk of postoperative complications, such as severe preeclampsia. * Diabetes. * Collagen diseases. * Autoimmune diseases (rheumatoid arthritis, Crohn's disease). * Vascular diseases (vasculitis). * Coagulation disorders (thrombophilia). * Pregnant patients with premature rupture of membranes, since this may influence the choice of timing and method of cesarean section. * Pregnant patients diagnosed with chorioamnionitis, which represents an increased risk of postoperative infection. * Pregnant patients diagnosed with acute abdomen, which may require emergency surgical management that is not compatible with standard cesarean section procedures. * Pregnant patients with multiple pregnancies, since this could complicate the cesarean section procedure and affect the results of the study. * Presence of major fetal malformations that may require additional interventions at birth. * Fetal stillbirth
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cesarean section scar are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Escuela
Tegucigalpa, Francisco Morazán Department, 11101, Honduras
More trials for these conditions
Other studies related to the condition(s) this trial covers.